Article info

Download PDFPDF

Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG4-related disease’ by Simpson et al
Free

Authors

  1. Correspondence to Dr Mikael Ebbo, Internal Medicine, AP-HM, Hôpital de la Timone, Marseille, France; mikael.ebbo{at}ap-hm.fr
View Full Text

Citation

Ebbo M, De Sainte-Marie B, Muller R, et al
Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG4-related disease’ by Simpson et al

Publication history

  • Received January 17, 2020
  • Accepted January 20, 2020
  • First published January 29, 2020.
Online issue publication 
January 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.